Adverse events dependent on trial arm.
ADVERSE EVENTS
The adverse events for this study are separated into placebo, testosterone and OLE arms. Placebo = placebo phase, when the participants were provided with the placebo (either 0–12 weeks or 14–26 weeks depending on the participant). Testosterone = testosterone phase, when the participans were provided with testosterone (either 0–12 weeks or 14–26 weeks depending on the participant). OLE = open lable extension.